Date
18 November 2021
Millions Miss Out on Antibiotics in Echo of Vaccine Inequity
James Paton writes for Bloomberg Health about the findings of the 2021 Antimicrobial Resistance Benchmark.
Bloomberg reports on the launch of the 2021 AMR Benchmark, writing: "Efforts to widen access to antibiotics and reduce the threat of superbugs are running into the same problems that have kept Covid vaccines out of reach in many lower-income nations, a report shows."
“We’re going to repeat this inequity problem we had in Covid in this space,” the Access to Medicine Foundation's CEO Jayasree Iyer tells the publication. “So what are we really doing to stop the next pandemic?”